Featured Research

from universities, journals, and other organizations

British study may improve glaucoma assessment and treatment

Date:
October 24, 2011
Source:
Association for Research in Vision and Ophthalmology
Summary:
Results from a recent scientific study in the UK may change the way that healthcare professionals measure eye pressure and allow them to assess the risk of glaucoma with greater accuracy. Glaucoma is the second most common cause of irreversible loss of vision worldwide.

Results from a recent scientific study in the U.K. may change the way that healthcare professionals measure eye pressure and allow them to assess the risk of glaucoma with greater accuracy. Glaucoma is the second most common cause of irreversible loss of vision worldwide.

The study, published in the journal Investigative Ophthalmology & Visual Science, reports the distribution and causes of eye pressure -- medically termed intraocular pressure (IOP).

According to the authors, researchers have long recognized that the clinical methods of assessing eye pressure have suffered from some inaccuracies, specifically as a consequence of the physical properties of the cornea. The EPIC-Norfolk study presents the first large-scale population-based measures of corneal biomechanics.

"Previously, a rather crude measure -- central corneal thickness -- was used as an index of corneal biomechanics," said author Paul J. Foster, MD, PhD, FRCS(Ed), of the University College London Institute of Ophthalmology, "We used a device which generates measures of corneal biomechanics in conjunction with IOP and attempts to 'correct' IOP for corneal physical properties."

Recruited between 1993 and 1997, the EPIC-Norfolk cohort was made up of approximately 25,000 predominantly Caucasian men and women aged 40 to 79 living in eastern England. From 2006 to 2010, a health examination was conducted to objectively assess various physical, cognitive and ocular characteristics of participants. The research team used a non-contact tonometer, the Ocular Response Analyzer, to obtain eye pressure and corneal biomechanical data from 4,184 study participants, now aged 48 to 91 years.

"The accurate measurements of IOP and interpretation of the results in terms of what is seen in the 'normal' population are cardinal pieces of information when healthcare professionals conduct routine eye examinations," said Foster. "We will be using our results to assess the validity of current glaucoma treatment guidelines, with respect to levels of risk attributed to specific levels of IOP."


Story Source:

The above story is based on materials provided by Association for Research in Vision and Ophthalmology. Note: Materials may be edited for content and length.


Journal Reference:

  1. P. J. Foster, D. C. Broadway, D. F. Garway-Heath, J. L. Y. Yip, R. Luben, S. Hayat, N. Dalzell, N. J. Wareham, K.-T. Khaw. Intraocular Pressure and Corneal Biomechanics in an Adult British Population: The EPIC-Norfolk Eye Study. Investigative Ophthalmology & Visual Science, 2011; 52 (11): 8179 DOI: 10.1167/iovs.11-7853

Cite This Page:

Association for Research in Vision and Ophthalmology. "British study may improve glaucoma assessment and treatment." ScienceDaily. ScienceDaily, 24 October 2011. <www.sciencedaily.com/releases/2011/10/111024133039.htm>.
Association for Research in Vision and Ophthalmology. (2011, October 24). British study may improve glaucoma assessment and treatment. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/10/111024133039.htm
Association for Research in Vision and Ophthalmology. "British study may improve glaucoma assessment and treatment." ScienceDaily. www.sciencedaily.com/releases/2011/10/111024133039.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins